Replay available

Perimeter Medical Imaging AI, Inc. (PINK) Q1 2025 Earnings Call

Perimeter Medical Imaging AI, Inc. (TSXV: PINK) Q1 2025 earnings conference call, held 2025-05-13. Replay captured from the company's public earnings webcast.

Tue, May 13, 2025 at 5:00 PMendedReplay
Perimeter Medical Imaging AI, Inc. (PINK) Q1 2025 Earnings Call

Hosted by

Featured presenters

Stephen Kilmer

Investor Relations

Sarah O'Brien

Chief Financial Officer

Adrian Mendez

Chief Executive Officer

Andrew Berkley

Chief Innovation Officer & Co-founder

Michael Freeman

Analyst, Raymond James

Scott McCauley

Analyst, Paradigm Capital

Dog Glow

Analyst, Lead Financial

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Perimeter Medical Imaging Ai Inc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.194 This time, all lines are in listen-only mode. 00:00:03.194 -- 00:00:06.777 Following the presentation, we will conduct a question and answer session. 00:00:06.777 -- 00:00:11.862 If at any time during this call you require immediate assistance, please 00:00:11.862 -- 00:00:17.127 press star zero for the operator. This call is being recorded on Tuesday, May 13, 00:00:17.127 -- 00:00:19.127 2025. 00:00:19.129 -- 00:00:21.552 I would now like to turn the conference over to Mr. 00:00:21.552 -- 00:00:26.334 Stephen Kilmer of Investor Relations. Please go ahead. 00:00:26.536 -- 00:00:31.091 Thank you. Good afternoon, everyone. Let me start by pointing out that this conference 00:00:31.091 -- 00:00:35.458 call will include four linking statements within the meaning of applicable 00:00:35.458 -- 00:00:40.206 securities laws. These may include statements regarding the future financial position, 00:00:40.206 -- 00:00:45.575 business strategy and strategic goals, commercial activities and timing, competitive 00:00:45.575 -- 00:00:50.843 conditions, research and development activities, projected costs and capital expenditures, 00:00:50.843 -- 00:00:55.581 research and clinical testing outcomes, the potential benefits of our products, including 00:00:55.581 -- 00:01:00.770 perimeter S-series OCT, perimeter B-series OCT, and perimeter 00:01:00.770 -- 00:01:06.059 image assist. Perimeter's ability to broaden its user base and the expected approval 00:01:06.059 -- 00:01:11.107 of its proprietary AI. Expectations regarding new products and the timing 00:01:11.107 -- 00:01:16.096 thereof, and expectations regarding opportunities for market expansion. 00:01:16.096 -- 00:01:19.461 Forward-looking statements are subject to numerous risks and uncertaint...